Clinical Trials
5 trialsNCT05682209 2023-01-18
The Effect of Octreotide on Wound Drainage After Mastectomy
University College Hospital, Ibadan
Phase 4 Completed
NCT03791736 2022-07-28
SANDOSTATINE
Institut Cancerologie de l'Ouest
Phase NA Terminated
NCT00002864 2020-04-01
Tamoxifen With or Without Octreotide in Treating Postmenopausal Women With Stage I, Stage II, or Stage III Breast Cancer
Canadian Cancer Trials Group
Phase 3 Completed
NCT00226967 2020-01-27
Stress, Diurnal Cortisol, and Breast Cancer Survival
Stanford University
Completed
NCT02294786 2019-07-15
Study of Prophylactic Octreotide to Prevent or Reduce the Frequency and Severity of Diarrhoea in Subjects Receiving Lapatinib With Capecitabine for the Treatment of Metastatic Breast Cancer
Novartis
Phase 2 Terminated